These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7076763)

  • 41. [Simultaneous determination of quinidine and hydroquinidine in in the presence of benzodiazepine in human plasma].
    Quaglio MP; Bellini AM
    Farmaco Prat; 1988 Feb; 43(2):47-55. PubMed ID: 3396688
    [No Abstract]   [Full Text] [Related]  

  • 42. Liquid chromatographic determination of quinidine in serum and urine.
    Patel CP
    Ther Drug Monit; 1982; 4(2):213-7. PubMed ID: 7101389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous liquid chromatographic analysis of ritonavir, quinine and 3-hydroxyquinine in human plasma.
    Soyinka JO; Onyeji CO; Omoruyi SI
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):441-5. PubMed ID: 19147413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinidine determination in serum: enzyme immunoassay (EIA) V HPLC.
    Ha HR; Kewitz G; Wenk M; Follath F
    Br J Clin Pharmacol; 1981 Mar; 11(3):312-4. PubMed ID: 7011351
    [No Abstract]   [Full Text] [Related]  

  • 45. Specificity of quinidine determination methods.
    Guentert TW; Riegelman S
    Clin Chem; 1978 Nov; 24(11):2065-6. PubMed ID: 709852
    [No Abstract]   [Full Text] [Related]  

  • 46. Dihydroquinidine contamination of quinidine raw materials and dosage forms: rapid estimation by high-performance liquid chromatography.
    Narang PK; Crouthamel WG
    J Pharm Sci; 1979 Jul; 68(7):917-9. PubMed ID: 458617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of an enzyme immunoassay and a high performance liquid chromatographic method for quantitation of quinidine in serum.
    Dextraze PG; Foreman J; Griffiths WC; Diamond I
    Clin Toxicol; 1981 Mar; 18(3):291-7. PubMed ID: 7016419
    [No Abstract]   [Full Text] [Related]  

  • 48. Thin-layer chromatography for the quantitative separation of quinidine and quinidine metabolites from biological fluids and tissues.
    Härtel G; Korhonen A
    J Chromatogr; 1968 Sep; 37(1):70-5. PubMed ID: 5683270
    [No Abstract]   [Full Text] [Related]  

  • 49. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R; Moulin MA; Charbonneau P; Bazin C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-performance liquid chromatographic analysis of quinine and its diastereoisomer quinidine.
    Mihaly GW; Hyman KM; Smallwood RA; Hardy KJ
    J Chromatogr; 1987 Mar; 415(1):177-82. PubMed ID: 3584354
    [No Abstract]   [Full Text] [Related]  

  • 52. Simultaneous high-performance liquid chromatographic assay for quinidine, disopyramide and the mono-N-dealkylated metabolite of disopyramide.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Chromatogr; 1982 Jul; 230(2):433-7. PubMed ID: 7107788
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of two spectrofluormetric procedures for quinidine determination in biological fluids.
    Huynh-ngoc T; Sirois G
    J Pharm Sci; 1977 Apr; 66(4):591-2. PubMed ID: 856981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The specificity of the extraction fluorescence assay for serum or plasma quinidine.
    Greenblatt DJ; Woo E
    J Clin Pharmacol; 1981; 21(8-9):333-6. PubMed ID: 7024328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of electrocardiographic changes with plasma quinidine concentration.
    Gonzalez ER; Meyers DG
    Nebr Med J; 1985 Mar; 70(3):87-91. PubMed ID: 3982553
    [No Abstract]   [Full Text] [Related]  

  • 57. Isolation, characterisation and synthesis of a new quinidine metabolite.
    Guentert TW; Daly JJ; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):31-8. PubMed ID: 7067721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic drug monitoring of quinidine].
    Yamada K; Hori R
    Nihon Rinsho; 1990 Feb; 48 Suppl():1156-8. PubMed ID: 2355516
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous determination of antiarrhythmia drugs by high-performance thin-layer chromatography.
    Lee KY; Nurok D; Zlatkis A
    J Chromatogr; 1978 Oct; 158():403-10. PubMed ID: 721938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.